Neuroprotective Effects of Aldehyde-Reducing Composition in an LPS-Induced Neuroinflammation Model of Parkinson’s Disease
Molecules · 07.12.2023 · 28 (24) · 7988
DOI: 10.3390/molecules28247988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 07.12.2023. Verfasst von Sora Kang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Parkinson Disease, Neuroprotective Agents, Neurodegenerative Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Picoentech, PICOENTECH Co., Ltd..
Abstract (Originalsprache)
Parkinson’s disease (PD) is a complex neurodegenerative disease in which neuroinflammation and oxidative stress interact to contribute to pathogenesis. This study investigates the in vivo neuroprotective effects of a patented yeast extract lysate in a lipopolysaccharide (LPS)-induced neuroinflammation model. The yeast extract lysate, named aldehyde-reducing composition (ARC), exhibited potent antioxidant and anti-aldehyde activities in vitro. Oral administration of ARC at 10 or 20 units/kg/day for 3 days prior to intraperitoneal injection of LPS (10 mg/kg) effectively preserved dopaminergic neurons in the substantia nigra (SN) and striatum by preventing LPS-induced cell death. ARC also normalized the activation of microglia and astrocytes in the SN, providing further evidence for its neuroprotective properties. In the liver, ARC downregulated the LPS-induced increase in inflammatory cytokines and reversed the LPS-induced decrease in antioxidant-related genes. These findings indicate that ARC exerts potent antioxidant, anti-aldehyde, and anti-inflammatory effects in vivo, suggesting its potential as a disease-modifying agent for the prevention and treatment of neuroinflammation-related diseases, including Parkinson’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
- Picoentech Co., Ltd., Seongnam-si 13201, Gyeong gi-do, Republic of Korea.
- Department of Biomedical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Physiology, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
ORCID-Profile: Sora Kang, Hye Ji Yoon, Suyeol Im, Youngmi Kim Pak
Förderung
- National Research Foundation of Korea
- Picoentech
- PICOENTECH Co., Ltd.
Zitieren
APA
Kang, S., Noh, Y., Oh, S. J., Yoon, H. J., Im, S., Kwon, H. T., & Pak, Y. K. (2023). Neuroprotective Effects of Aldehyde-Reducing Composition in an LPS-Induced Neuroinflammation Model of Parkinson’s Disease. Molecules, 28(24), 7988. https://doi.org/10.3390/molecules28247988
Vancouver
Kang S, Noh Y, Oh SJ, Yoon HJ, Im S, Kwon HT, et al. Neuroprotective Effects of Aldehyde-Reducing Composition in an LPS-Induced Neuroinflammation Model of Parkinson’s Disease. Molecules. 2023;28(24):7988. doi:10.3390/molecules28247988
BibTeX
@article{Kang2023,
author = {Kang, Sora and Noh, Youngjin and Oh, Seung Jun and Yoon, Hye Ji and Im, Suyeol and Kwon, Hung Taeck and Pak, Youngmi Kim},
title = {Neuroprotective Effects of Aldehyde-Reducing Composition in an LPS-Induced Neuroinflammation Model of Parkinson’s Disease},
journal = {Molecules},
year = {2023},
volume = {28},
number = {24},
pages = {7988},
doi = {10.3390/molecules28247988}
}
EUVIMED